Multicentre Covariate Adjustment Analysis of Short-Term and 5-Year Outcomes after Endovascular Repair according to Sex.

Bibombe Patrice MwipatayiRebekah L W TanJoseph FarajAli DaneshmandOlufemi OshinNishath AltafShannon D ThomasPatrik J TosenovskyJackie WongVikram VijayanAnthony J FreemanSally A Burrows

Published in: Surgery research and practice (2020)

This study found no significant differences in 30-day and 5-year outcomes between female and male patients treated with EVAR, implying that EVAR remains a safe treatment choice for female patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
prognostic factors
peritoneal dialysis
randomized controlled trial
study protocol
patient reported outcomes
metabolic syndrome
decision making